ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Prostate Cancer Patient Groups Consider formation Of Coalition Using the “NBCC Model”

August 16, 1996

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

Letter In Response To Hadley; RFA Available

July 7, 1995

White House Backs Down FY 86 Cuts, Says Now They Will Be Limited To Trimming Indirect Costs

January 10, 1986

Bush Says National Dialogue On Cancer Needs To Correct Problems And Move On.

March 17, 2000

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

October 5, 1979